文献速递其他结缔组织病

欧洲两家儿童风湿病中心幼年皮肌炎治疗与结局比较

Comparison of treatments and outcomes of children with juvenile dermatomyositis followed at two European tertiary care referral centers.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

该研究回顾性比较了意大利热那亚Gaslini研究所与英国伦敦大奥蒙德街医院2000至2015年收治的127例幼年皮肌炎(JDM)患儿的治疗选择和疾病结局。两中心在药物选择上存在显著差异,但24个月时约四分之三患者疾病无活动,且损伤频率低,提示现代治疗改善了结局。

要点

  • 两中心在JDM药物选择上存在显著差异,英国更常用环磷酰胺、硫唑嘌呤、英夫利昔单抗、利妥昔单抗和吗替麦考酚酯。
  • 意大利中心更常使用环孢素、静脉注射免疫球蛋白和羟氯喹。
  • 24个月时约四分之三患者疾病无活动,英意两国分别有38.6%和36%的患者存在损伤。

核心结论

  • 两中心儿童风湿病医生在JDM药物选择上存在显著差异,但24个月时高比例患者疾病无活动且损伤频率低,现代治疗改善了结局。

研究设计与样本

  • 回顾性队列研究,纳入2000年1月至2015年12月在意大利Gaslini研究所或英国大奥蒙德街医院就诊、起病6个月内入组并随访至少6个月的JDM患者,共127例(英国88例,意大利39例)。

主要发现

  • 24个月时肌肉力量和疾病活动度中位数处于正常端,约四分之三患者疾病无活动。
  • 24个月时英国38.6%、意大利36%的患者存在损伤。
  • 英国医生更常使用环磷酰胺、硫唑嘌呤、英夫利昔单抗、利妥昔单抗和吗替麦考酚酯,意大利医生更常使用环孢素、静脉注射免疫球蛋白和羟氯喹。

临床怎么用

  • 两中心JDM治疗选择差异显著,但24个月时多数患者疾病无活动且损伤频率低,提示不同治疗策略均可获得较好结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To compare the treatment approaches and disease outcomes of children with JDM followed in two European tertiary care peadiatric rheumatology centres. METHODS: The medical notes of patients with JDM seen at Istituto Giannina Gaslini (IGG) of Genoa, Italy or Great Ormond Street Hospital (GOSH) of London, UK between January 2000 and December 2015 within 6 months after disease onset and followed for at least 6 months were reviewed. Demographic, clinical and therapeutic data were collected. At each visit, the caring physician was asked to rate the disease state subjectively. RESULTS: A total of 127 patients were included, 88 at GOSH and 39 at IGG. At 24 months, the median values of muscle strength and disease activity were at the normal end of the scale and around three quarters of patients were said to have inactive disease. Also, at 2 years, 38.6% and 36% of British and Italian patients, respectively, had damage. Cyclophosphamide, azathioprine, infliximab, rituximab and mycophenolate mofetil were used more frequently by UK physicians, whereas ciclosporin, intravenous immunoglobulin and hydroxychloroquine were prescribed by Italian physicians. CONCLUSION: This study shows a significant difference in the choice of medications between pediatric rheumatologists practising in the two centres. Despite this, a high proportion of patients had inactive disease at 2 years and there was a low frequency of damage: modern treatments have improved outcomes.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Varnier GC, Consolaro A, Maillard S, et al. Comparison of treatments and outcomes of children with juvenile dermatomyositis followed at two European tertiary care referral centers. Rheumatology (Oxford). 2021. PMID: 33528490. doi:10.1093/rheumatology/keab089

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。